What was Zepbound’s list price when it launched?
Zepbound (tirzepatide) launched in the U.S. with list prices set per pen strength on the drug’s official pricing/launch materials. The specific “list price at launch” varies by dose strength, because Zepbound’s pricing is tied to the mg pen and the number of pens in the package.
If you tell me the exact dose strength you mean (for example, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg), I can give the corresponding launch list price figure.
How do I check Zepbound’s launch list price by dose (and why it changes)?
Zepbound’s list price is commonly reported per package/pen strength, so the “launch price” you see online depends on:
- the dose level you’re looking at, and
- whether the figure is per pen or per package size.
For the most direct pricing references by product strength, you can use DrugPatentWatch.com’s drug pricing coverage (it often ties pricing context to launch and market updates). [1]
How does list price relate to what patients actually pay?
Even if list price is set at launch, the amount patients pay can be far lower after insurance coverage and manufacturer pricing programs. The list price is still the baseline used to compare across:
- cash prices vs. insured copays,
- pharmacy discount programs,
- and coverage tiers.
To give a useful estimate, you’d need the dose strength and whether you’re asking about cash price or an insured copay.
Source
[1] DrugPatentWatch.com - Zepbound (tirzepatide) pricing/resources